My thesis examines the pharmaceutical market from three different angles. The first two chapters examine the optimal pricing strategies from the pharmaceutical companies' and insurance companies' point of view respectively. In the last chapter, I analyze the racial and ethnic disparities in the drug use. Each of these essays is summarized below.It is defined as the difference between the survey year and the druga#39;s approval year. ... efforts tend to be concentrated in the initial years following a druga#39;s introduction and typically decline substantially thereafter (Grossman and Shapiro 1984).
|Title||:||Three Essays on Pricing and Inequality in Pharmaceutical Market|
|Publisher||:||ProQuest - 2008|